STEMart Announces Enhanced In Vivo Rat Micronucleus Test Services to Accelerate Medical Device Biocompatibility Testing
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test…